[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

JP2017101118A5 - - Google Patents

Download PDF

Info

Publication number
JP2017101118A5
JP2017101118A5 JP2015233571A JP2015233571A JP2017101118A5 JP 2017101118 A5 JP2017101118 A5 JP 2017101118A5 JP 2015233571 A JP2015233571 A JP 2015233571A JP 2015233571 A JP2015233571 A JP 2015233571A JP 2017101118 A5 JP2017101118 A5 JP 2017101118A5
Authority
JP
Japan
Prior art keywords
group
salt
formula
compound
carbon atoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015233571A
Other languages
Japanese (ja)
Other versions
JP6685546B2 (en
JP2017101118A (en
Filing date
Publication date
Application filed filed Critical
Priority to JP2015233571A priority Critical patent/JP6685546B2/en
Priority claimed from JP2015233571A external-priority patent/JP6685546B2/en
Publication of JP2017101118A publication Critical patent/JP2017101118A/en
Publication of JP2017101118A5 publication Critical patent/JP2017101118A5/ja
Application granted granted Critical
Publication of JP6685546B2 publication Critical patent/JP6685546B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (12)

下記一般式(I)で表される化合物またはその塩:
A−S−B (I)
(ここで、式(I)中、Aは、下記の式(A−1)〜(A−13)からなる群より選択されるいずれか一つを示し:
Figure 2017101118
Figure 2017101118
ここで、上記に列挙される各式(A−1)〜(A−13)中のRnは、水素原子;炭素数1〜15の直鎖型若しくは分枝型のアルキル基;炭素数1〜10の直鎖型若しくは分枝型のエーテル;フェニル基;フェニル基の一部をアミノ基、ハロゲン、ニトロ基に置換したフェニル基;アミノ基;シアノ基;ニトロ基;カルボン酸若しくはその塩若しくはエステル若しくはアミド;スルホン酸若しくはその塩若しくはエステル若しくはアミド;チオール基;水酸基若しくはその塩;ケトン;ハロゲン;または糖を示す。nは置換基Rの数を示す1〜8の整数であって、nが2以上の場合、各Rは、互い同一であっても異なっていてもよい。また、※はSとの結合手を示す。
また、式(I)中、Bは、下記式(B)で表される:
Figure 2017101118
ここで、式(B)中、※はSとの結合手を示す。
また、式(I)中、Sは炭素数2もしくは4のアルケニル基、または、炭素数2もしくは4のアルキニル基を示す。)
A compound represented by the following general formula (I) or a salt thereof:
A-S-B (I)
(In the formula (I), A represents any one selected from the group consisting of the following formulas (A-1) to (A-13):
Figure 2017101118
Figure 2017101118
Here, R n in each of the formulas (A-1) to (A-13) listed above is a hydrogen atom; a linear or branched alkyl group having 1 to 15 carbon atoms; -10 linear or branched ether; phenyl group; phenyl group in which part of the phenyl group is substituted with amino group, halogen, nitro group; amino group; cyano group; nitro group; carboxylic acid or salt thereof; Ester or amide; sulfonic acid or salt or ester or amide; thiol group; hydroxyl group or salt thereof; ketone; halogen; n is an integer of 1 to 8 indicating the number of substituents R. When n is 2 or more, each R may be the same as or different from each other. * Indicates a bond with S.
In the formula (I), B is represented by the following formula (B):
Figure 2017101118
Here, in formula (B), * indicates a bond with S.
In formula (I), S represents an alkenyl group having 2 or 4 carbon atoms or an alkynyl group having 2 or 4 carbon atoms. )
請求項1に記載の化合物またはその塩であって、
前記式(I)中、Aが、下記の式(A−5)、(A−7)、(A−8)、(A−12)、または、(A−13)である、化合物またはその塩:
Figure 2017101118
Figure 2017101118
(ここで、上記式(A−5)、(A−7)、(A−8)、(A−12)、または、(A−13)中のRnは、水素原子;炭素数1〜15の直鎖型若しくは分枝型のアルキル基;炭素数1〜10の直鎖型若しくは分枝型のエーテル;フェニル基;フェニル基の一部をアミノ基、ハロゲン、ニトロ基に置換したフェニル基;アミノ基;シアノ基;ニトロ基;カルボン酸若しくはその塩若しくはエステル若しくはアミド;スルホン酸若しくはその塩若しくはエステル若しくはアミド;チオール基;水酸基若しくはその塩;ケトン;ハロゲン;または糖を示す。nは置換基Rの数を示す1〜8の整数であって、nが2以上の場合、各Rは互いに同一であっても異なっていてもよい。また、※はSとの結合手を示す)。
A compound according to claim 1 or a salt thereof,
In the above formula (I), A is the following formula (A-5), (A-7), (A-8), (A-12), or (A-13), or a compound thereof salt:
Figure 2017101118
Figure 2017101118
(Here, R n in the above formulas (A-5), (A-7), (A-8), (A-12), or (A-13) represents a hydrogen atom; 15 linear or branched alkyl groups; linear or branched ethers having 1 to 10 carbon atoms; phenyl groups; phenyl groups in which part of the phenyl groups are substituted with amino groups, halogens, or nitro groups Amino group; cyano group; nitro group; carboxylic acid or salt or ester or amide; sulfonic acid or salt or ester or amide; thiol group; hydroxyl group or salt thereof; It is an integer of 1 to 8 indicating the number of groups R, and when n is 2 or more, each R may be the same or different from each other, and * indicates a bond with S).
請求項1または2に記載の化合物またはその塩であって、
前記式(I)中、Aが、下記の式(A−5)または(A−7)である、化合物またはその塩:
Figure 2017101118
(ここで、上記式(A−5)または(A−7)中のRnは、水素原子;炭素数1〜15の直鎖型若しくは分枝型のアルキル基;炭素数1〜10の直鎖型若しくは分枝型のエーテル;フェニル基;フェニル基の一部をアミノ基、ハロゲン、ニトロ基に置換したフェニル基;アミノ基;シアノ基;ニトロ基;カルボン酸若しくはその塩若しくはエステル若しくはアミド;スルホン酸若しくはその塩若しくはエステル若しくはアミド;チオール基;水酸基若しくはその塩;ケトン;ハロゲン;または糖を示す。nは置換基Rの数を示す1〜8の整数であって、nが2以上の場合、各Rは互いに同一であっても異なっていてもよい。また、※はSとの結合手を示す)。
The compound according to claim 1 or 2 or a salt thereof,
In the formula (I), a compound represented by the following formula (A-5) or (A-7) or a salt thereof:
Figure 2017101118
(Here, R n in the above formula (A-5) or (A-7) represents a hydrogen atom; a linear or branched alkyl group having 1 to 15 carbon atoms; a straight chain having 1 to 10 carbon atoms; Chain-type or branched-type ether; phenyl group; phenyl group in which a part of phenyl group is substituted with amino group, halogen, nitro group; amino group; cyano group; nitro group; carboxylic acid or its salt or ester or amide; A thiol group, a hydroxyl group or a salt thereof, a ketone, a halogen, or a sugar, n is an integer of 1 to 8 that represents the number of substituents R, and n is 2 or more In this case, each R may be the same as or different from each other, and * indicates a bond with S).
請求項1〜3のいずれか一項に記載の化合物であって、
前記式(I)中、Sが炭素数2のアルケニル基である、化合物またはその塩。
A compound according to any one of claims 1-3,
In the above formula (I), a compound or a salt thereof, wherein S is an alkenyl group having 2 carbon atoms.
請求項1〜4のいずれか一項に記載の化合物であって、鉄イオンと錯体を形成している化合物。   The compound according to any one of claims 1 to 4, wherein the compound forms a complex with an iron ion. 請求項1〜5のいずれか一項に記載の化合物またはその塩を含む蛍光試薬。   The fluorescent reagent containing the compound or its salt as described in any one of Claims 1-5. ドーパミン検出用蛍光試薬である、請求項6に記載の蛍光試薬。   The fluorescent reagent according to claim 6, which is a fluorescent reagent for detecting dopamine. 請求項1に記載の化合物またはその塩の中間体化合物であって、下記式(II)に示される化合物:
Figure 2017101118
(ここで、式(II)におけるR4およびR5は、保護基である。)
An intermediate compound of the compound according to claim 1 or a salt thereof, wherein the compound is represented by the following formula (II):
Figure 2017101118
(Here, R 4 and R 5 in formula (II) are protecting groups.)
式(II)で示される化合物の製造方法であって、
Figure 2017101118
(ここで、式(II)におけるR4およびR5は、保護基である。)
(a)下記式(III)で示される化合物、パラホルムアルデヒド、および、炭素数2〜4のアルコールを含む溶媒中に4−ヒドロキシベンズアルデヒドを溶解させる工程を含む、製造方法:
Figure 2017101118
(ここで、式(III)におけるR4およびR5は、保護基である。)
A process for producing a compound represented by formula (II), comprising:
Figure 2017101118
(Here, R 4 and R 5 in formula (II) are protecting groups.)
(a) A production method comprising a step of dissolving 4-hydroxybenzaldehyde in a solvent containing a compound represented by the following formula (III), paraformaldehyde, and an alcohol having 2 to 4 carbon atoms:
Figure 2017101118
(Here, R 4 and R 5 in formula (III) are protecting groups.)
式(I)で示される化合物の製造方法であって、
(a)下記式(III)で示される化合物、パラホルムアルデヒド、および、炭素数2〜4のアルコールを含む溶媒中に4−ヒドロキシベンズアルデヒドを溶解させる工程と、
Figure 2017101118
(ここで、式(III)におけるR4およびR5は、保護基である。);
(b)前記工程(a)により得られた化合物および蛍光色素を、炭素数1〜4のアルコールと第二級アミンまたは第三級アミンとを含む溶媒中で反応させる工程と、
(c)前記工程(b)で得られた化合物の保護基を、塩基性条件下で脱保護する工程と、
を含む、製造方法。
A process for producing a compound of formula (I), comprising:
(A) dissolving 4-hydroxybenzaldehyde in a solvent containing a compound represented by the following formula (III), paraformaldehyde, and an alcohol having 2 to 4 carbon atoms;
Figure 2017101118
(Wherein R 4 and R 5 in formula (III) are protecting groups);
(B) reacting the compound obtained in the step (a) and the fluorescent dye in a solvent containing an alcohol having 1 to 4 carbon atoms and a secondary amine or a tertiary amine;
(C) deprotecting the protecting group of the compound obtained in the step (b) under basic conditions;
Manufacturing method.
請求項6または7に記載の蛍光試薬を用いてドーパミンを検出または測定する方法であって、ドーパミンと前記蛍光試薬とを反応させて、前記蛍光試薬の蛍光強度の変化を測定する工程を含む方法。   A method for detecting or measuring dopamine using the fluorescent reagent according to claim 6, comprising a step of measuring a change in fluorescence intensity of the fluorescent reagent by reacting dopamine with the fluorescent reagent. . 生体において神経細胞から放出されたドーパミンを検出または測定する方法であって、
ドーパミンを測定したい部位に請求項6または7に記載の蛍光試薬を投与する工程と、
当該蛍光試薬の蛍光を測定する工程と、
を含む、方法。
A method for detecting or measuring dopamine released from nerve cells in a living body,
Administering the fluorescent reagent according to claim 6 or 7 to a site where dopamine is to be measured;
Measuring the fluorescence of the fluorescent reagent;
Including a method.
JP2015233571A 2015-11-30 2015-11-30 Fluorescent substance for dopamine detection Active JP6685546B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2015233571A JP6685546B2 (en) 2015-11-30 2015-11-30 Fluorescent substance for dopamine detection

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2015233571A JP6685546B2 (en) 2015-11-30 2015-11-30 Fluorescent substance for dopamine detection

Publications (3)

Publication Number Publication Date
JP2017101118A JP2017101118A (en) 2017-06-08
JP2017101118A5 true JP2017101118A5 (en) 2018-12-13
JP6685546B2 JP6685546B2 (en) 2020-04-22

Family

ID=59016980

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015233571A Active JP6685546B2 (en) 2015-11-30 2015-11-30 Fluorescent substance for dopamine detection

Country Status (1)

Country Link
JP (1) JP6685546B2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109971478B (en) * 2017-12-28 2023-05-26 南京工业大学 Method for detecting dopamine by using terbium ion doped nano particles in fluorescence dual-wavelength manner
JP7450254B2 (en) * 2019-06-28 2024-03-15 国立研究開発法人産業技術総合研究所 How to measure neurotransmitters
CN111829999B (en) * 2020-07-23 2021-06-25 重庆大学 Application method of perovskite fluorescent microsphere and dopamine system

Similar Documents

Publication Publication Date Title
RU2014117188A (en) METHOD FOR PRODUCING 4,4-DIFTOR-3,4-DIHYDROISOCHINOLINE DERIVATIVES
RU2018111201A (en) FUNGICIDAL COMPOSITION FOR APPLICATION IN AGRICULTURE AND GARDENING
EP4248988A3 (en) Alkenyl substituted 2,5-piperazinediones and their use in compositions for delivering an agent to a subject or cell
JP2014510114A5 (en)
JP2017508789A5 (en)
RU2015103694A (en) METHODS FOR SYNTHESIS OF SPIRO-OXINDOL COMPOUNDS
PE20160678A1 (en) MARKED MEMBRANE-SPECIFIC PROSTATIC ANTIGEN INHIBITORS (PSMA), THEIR USE AS IMAGING AGENTS AND PHARMACEUTICAL AGENTS FOR THE TREATMENT OF PROSTATE CANCER
EA201890752A1 (en) METHOD OF OBTAINING ANTI-FIBER CONNECTIONS
CY1124387T1 (en) METHOD FOR PRODUCING A NEW NITROGEN-CONTAINING CHEMICAL COMPOUND OR SALT THEREOF, AND PRODUCING AN INTERMEDIATE THEREOF
RU2015113638A (en) CRYSTALLINE SUBSTANCE AND PHARMACEUTICAL PRODUCT CONTAINING IT
JP2014520901A5 (en)
RU2019131147A (en) NEW CHINAZOLINE DERIVATIVES INHIBITING PI3K AND THEIR PHARMACEUTICAL COMPOSITION
JP2017515919A5 (en)
CY1121484T1 (en) SALT AND CRYSTAL FORMS OF AN SUSPENDER PLK-4
JP2017101118A5 (en)
JP2014043437A5 (en) Organic compounds
RU2014129937A (en) METHODS AND INTERMEDIATE COMPOUNDS FOR PRODUCING PHARMACEUTICAL AGENTS
JP2014167003A5 (en)
RU2014124531A (en) (1R, 4R) 7-OXO-2-AZABICYCLO [2.2.2] OCT-5-EH AND ITS DERIVATIVES
RU2018104555A (en) NEW CONNECTION SPECIFICALLY RELATING TO THE AMPA RECEPTOR
JP2015524456A5 (en)
RU2015120527A (en) Ethyl ethers of 2-amino-1-benzoylamino-4-oxo-5- (2-oxo-2-arylethylidene) -4,5-dihydro-1H-pyrrolidine-3-carboxylic acids, which is beneficial in some respects.
JP2016507477A5 (en)
CU20120041A7 (en) NEW DIHIDRO-OXAZOLOBENZODIAZEPINONAS DERIVATIVES, THEIR PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
EA201400437A1 (en) Method of producing alcoxyaryl ether